Navigation Links
Novexel to be Acquired by AstraZeneca
Date:12/23/2009

rica. - NXL103, an oral Streptogramin antibiotic. NXL103 is currently in a Phase II clinical trial in adults with acute bacterial skin and skin structure infections (ABSSSI). The trial is designed to assess the safety and efficacy of NXL103 in comparison to oral linezolid. NXL103 has already delivered positive Phase II results in a trial evaluating it in the treatment of community acquired pneumonia (CAP).

In addition, Novexel has two further programmes in preclinical development: NXL105, a novel anti-Pseudomonal antibiotic and NXL201, a novel echinocandin antifungal agent.

Iain Buchanan, Novexel's CEO, said, "Today's announcement highlights the significant progress that Novexel has made since it was spun out of Aventis Pharma S.A. in December 2004 and demonstrates the added value of placing promising assets in an entrepreneurial structure in France. Over the last five years we have made the appropriate decisions to advance the pipeline and I would like to pay tribute to all Novexel employees whose collective efforts have made this transaction with AstraZeneca possible. I am confident that the acquired assets will receive continued investment from both AstraZeneca and Forest and will have the possibility to play an important therapeutic role to combat resistant organisms in the hospital."

Goldman Sachs acted as financial advisor to Novexel on this transaction.

Notes to Editors

About Novexel

Novexel is a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The ever increasing resistance to marketed antibiotics has led to a clear need for

novel drugs that are active against multi-drug resistant bacteria. Novexel's products are targeting the global hospital antibiotic market, which was worth an estimate
'/>"/>

SOURCE Novexel
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
2. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
3. Novexels NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
4. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
5. Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
6. Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
7. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
8. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
9. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
10. Enanta Reports New Macrolide-Related Drug Class, Bicyclolides, to Combat Hospital and Community Acquired Superbug Infections, Including MRSA
11. Wyeth Receives Approvable Letter from FDA for TYGACIL for the Treatment of Patients with Community-Acquired Pneumonia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... , April 24, 2015   Vestagen Technical ... technology, VESTEX ® , has recently received two notable ... a global competition that recognizes innovations with potential to ... ceremony last night in New York City ... the Material Science "Protection & Safety" category. The awards ...
(Date:4/24/2015)... Apr. 24, 2015 Research and Markets ... the addition of the "Lab Accessories ... Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station) & End User (OEM/Biotechnology ... Forecast to 2020" report to their ... market is expected to reach $504.7 million ...
(Date:4/24/2015)... , April 24, 2015 Hi-Tech Pharmaceuticals ... was not the product of reliable scientific principles ... reliable basis for allegations of adulteration. The FDA ... a false premise, or misguided hope, that Methylphenylethylamine ... studies are contradicted by multiple other studies and ...
Breaking Medicine Technology:VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 2VESTEX Wins Innovation Honors from Edison Awards & Apparel Magazine 3Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 2Global Lab Accessories Market Report 2015-2020 - Label Printer/ Pipette tips/ Pumps/Microplate/Reagent Reservoir/Valve/Tubing/Wash Station 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 2Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 3Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 4Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 5Hi-Tech Responds to "Bullying Tactics" Issued by FDA on Acacia Rigidula 6
... Kimberly-Clark Corporation (NYSE: KMB ) announced today ... business, which includes a number of innovative, minimally-invasive radio-frequency ... the exclusive distributor of Baylis Medical,s pain management products ... improves the competitive position of Kimberly-Clark Health Care in ...
... Oct. 5 US Oncology, Inc. ... (EHR) system, iKnowMed , at the American ... EHR Symposium: Harnessing the EHR: From Incentives to Sustainability ... iKnowMed(TM) addresses the unique needs of community-based medical oncologists. The ...
Cached Medicine Technology:Kimberly-Clark Acquires Baylis Medical Company's Pain Management Business 2Kimberly-Clark Acquires Baylis Medical Company's Pain Management Business 3US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability 2US Oncology, Inc. to Exhibit iKnowMed(TM) at the 2009 ASCO EHR Symposium: Harnessing the EHR: From Incentives to Sustainability 3
(Date:4/24/2015)... (PRWEB) April 24, 2015 The Fastest Fat ... after their great success of the Xtreme Fat Loss Diet, ... The fat loss blueprint that claims to help one ... attention of HealthyandFitZone.com's Stan Stevenson, prompting an investigative review. , ... that the creators spent years researching and experimenting with these ...
(Date:4/24/2015)... April 24, 2015 Lowcostcarinsuranceprice.com has released ... low cost auto insurance for senior citizens . ... but this does not mean that they cannot find ... senior drivers can find the right coverage for their ... brokerage website like http://lowcostcarinsuranceprice.com/ provides free leads ...
(Date:4/24/2015)... “Kind,” “selfless,” “the voice of reason” and ... Weiner described pediatric oncology nurse Laura Vasquez of Children’s ... during her five-year battle with a malignant brain tumor. ... and numerous experimental treatments, Vasquez continued caring for Alexa, ... was not in the hospital and even sitting vigil ...
(Date:4/24/2015)... April 24, 2015 “ Opera ” was ... which features the latest and coolest technology products available to ... NewsWatch, conducted the review and shared with viewers how this ... web browsers, surfing the internet would not be in existence. ... and the Opera browser is no different. Celebrating their 20th ...
(Date:4/24/2015)... Yisrayl Hawkins, Pastor and Overseer at The House ... armed forces are used worldwide, and how they would not ... Yisrayl says that the nations have been trained to build ... added to the confusion and distrust. , “The nations ... captivity, forced compliance, unjust rules and laws, and the rape ...
Breaking Medicine News(10 mins):Health News:Fastest Fat Loss Week Ever Review Revealed on Healthy & Fit Zone 2Health News:Low Cost Auto Insurance Quotes for Senior Citizens 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 2Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 3Health News:CURE™ Magazine Names Pediatric Nurse Laura Vasquez from Children’s Hospital Los Angeles As Extraordinary Healer™ of 2015 4Health News:A Web Browser That Connects over 350 Million People was Featured on NewsWatch Television 2Health News:Armed Forces Would Not Be Necessary if Biblical Laws Were Followed, Says Yisrayl Hawkins in New Article 2
... American people,through the U.S. Agency for International Development ... U.N. Children,s Fund (UNICEF) for,medical supplies and to ... prevent the further spread of diarrhea in Djibouti., ... drinking water and poor,sanitation and hygiene conditions led ...
... genetics,(Nasdaq: DCGN ) today announced that it will ... at the Lazard Capital Markets 4th Annual,Healthcare Conference., ... on Tuesday, November,27 at the Palace Hotel, New York ... on deCODE,s website, http://www.decode.com, and those,interested in ...
... of aging, experts say , , FRIDAY, Nov. 23 (HealthDay News) ... rest. It,s a huge quality-of-life problem, experts say, because contrary ... sleep as younger adults. , "Sleep problems and sleep ... Harrison G. Bloom, a senior associate at the International Longevity ...
... are less enthused, brain scans find , THURSDAY, Nov. 22 ... paycheck may have a lot to do with how much ... the University of Bonn in Germany. , They used magnetic ... into pairs. Each pair, in adjoining brain scanners, were asked ...
... midday sleepiness, experts say, , , THURSDAY, Nov. 22 (HealthDay ... the Thanksgiving feast aren,t rare, and experts say a ... holiday. , It may have to do with the ... -- a chemical known to promote sleepiness, said Donna ...
... 21 The Female Health Company,(Amex: FHC ) ... Street,Analyst Forum 18th Annual Analyst Conference on Wednesday, November ... (on 43rd Street between 5th and,6th). The Company,s CEO, ... the conference at 11:50 a.m. Eastern Time (EST)., ...
Cached Medicine News:Health News:Sleep Problems Plague the Older Set 2Health News:Sleep Problems Plague the Older Set 3Health News:There's More Than Turkey Behind Holiday Yawns 2Health News:The Female Health Company to Present at Wall Street Analyst Forum Wednesday, November 28, 2007 2
... ULTRAVIST (iopromide) injection is ... agent for intravascular administration. Introduced in ... after becoming available in Europe, ULTRAVIST ... 75 countries. It has established a ...
The Mitek Restore System, designed in conjunction with Sanford S. Kunkel, M.D., offers instrumentation for all ACL Procedures....
The cordless Simon Dermatome with rechargeable battery is used to harvest split-thickness skin grafts and for debridement....
... quality and innovation has resulted in one ... Model C is an air dermatome especially ... in burn care surgery. The Model C ... same dedication to quality, durability and reliability ...
Medicine Products: